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Introduction
The outbreak of coronavirus 2019 disease (COVID-19) in Hubei, China, and the introduction of 
the virus into the Region of the Americas highlight the urgent need for clear, concise and con-
sistent communication. 
Risk communication encompasses all the basics of health communication but differs in the 
need for speed and reliance on trust. At times of crisis, leaders are called on to provide a quick, 
sensitive and trustworthy response. The public wants to know what you know, what you are 
doing about it and what they can or should do. 
COVID-19, a disease similar to other coronavirus infections like MERS and SARS and to influen-
za, is causing global concern and has been declared a public health emergency of international 
concern by the Director-General of the World Health Organization (WHO). There are many un-
knowns, and this leads to fear, mostly about what could happen. This makes effective risk com-
munication a strategic resource that can contribute to the success of the public health response 
in countries of the Americas.  
In an ideal situation, there would be time to plan, setting up a communication strategy and an 
action guide. But times such as these require immediate skills to communicate with the public. 
Risk communication is an integral component of public health risk management and a core 
capacity under the International Health Regulations. What follows are some suggestions, prin-
ciples and templates to guide you through. 
Protecting health and averting preventable deaths is the mission that we all share. We must en-
sure that public health communication is timely, transparent, based on correct information and 
science, but also honest and frank, showing empathy and understanding about the public’s con-
cerns. This type of communication will be essential to ensure that people understand the risks 
of COVID-19 and follow authorities’ recommendations to protect their health and the health of 
their loved ones.
1I. Key Concepts of 
Risk Communication
TRUST
Trust is the key principle in risk communication. 
Without this trust, the public will not believe or act 
on information provided by the health minister or 
other officials. Ways to maintain trust include:
• Don’t over-reassure. You can’t say everything 
will be OK if, in fact, you don’t know that. Say 
what you know and what the government is 
doing about it. Tell the public what they can do 
(e.g., Wash your hands, sneeze or cough into the 
inside of your elbow)
• Don’t minimize people’s concern. People are 
fearful. That’s a healthy reaction.
• COVID-19 is a scary disease.
• Don’t suggest that the public shouldn’t worry.
• Acknowledge the uncertainty.
• Don’t say that the government has the situation 
under control; instead say what the govern-
ment is doing.
• Express empathy, sometimes referred to as 
speaking from the heart. For example, don’t say, 
“I know how you feel.” Instead say, “It’s natural 
to feel anxiety. This is a worrisome situation for 
all of us.”
• Be the first out with the information. Tell the pub-
lic that there is a case or suspected case of COVID-
19 as soon as you know it. Don’t wait to release 
what already has become rumor.
• Acknowledge mistakes. If there is an error, correct 
it. That shows your human side and creates trust 
because you have not tried to hide information.
 
ANNOUNCING EARLY
Announcing early shows leadership, leads to trust, 
reduces the rumors and can save lives. The so-called 
“first announcement” should say what is known, 
what it means, what is being done (e.g., “Today the 
first laboratory-confirmed case of COVID-19 was 
diagnosed. We are conducting contact tracing. 
This in an imported case, and the patient is now in 
isolation to prevent disease spread…”)
• Delayed announcements create speculation, 
which leads people to wonder how really bad 
the situation must be.
• Avoid stigmatization. Many people of Chinese 
or Asian origin are suffering unwarranted dis-
crimination. As leaders, you need to make sure 
stigmatization is minimized, or it can lead pa-
tients to deny they have the disease or to hide 
and fail to seek the care they need.
• In this ever-connected world we cannot hide 
outbreaks.
• If you don’t know an answer to a question, say 
so. And then get the response later.
• Fear and concern are initial reactions to crises. 
What’s often described as panic is an adjustment 
reaction to uncertainty and unknown risk. Peo-
ple rarely panic although officials think they do.
2• Don’t use technical jargon when communicat-
ing with the public or the news media.
• Give people steps to protect their own health 
and the health of others.
• Set expectations, e.g., “We expect things to get 
worse before they get better.”
• Acknowledge that the situation will change 
and explain that you will provide updates when 
there is more information. (e.g., “This is an 
evolving situation and we will update you later 
with more details.”)  
 
TRANSPARENCY LEADS TO TRUST
There are limits. but the goal is to aim for total candor.
• Be transparent. Ensure that the criteria for tak-
ing different actions are clear and available (e.g., 
“We are vaccinating this group first because 
they are at greater risk” or “they are healthcare 
workers who are taking care of others.”) 
• Provide timely and transparent information 
that is technically correct and based on science.
• Explain the decision-making process (e.g. “We 
felt that by naming the individual we would 
stigmatize his family.”)
• Other limits to transparency include — but are 
not limited to — national security.
• Detail what still needs to be learned and where 
the gaps lie.
• Speak about the risks, benefits and challenges.
• When guidance changes explain the reasons why. 
 
INVOLVE THE COMMUNITY 
• The public is entitled to information that affects 
their health and the health of their families and 
therefore should be involved in the process of mes-
sage creation based on their reactions and feedback.
• Public perception of risk often does not match 
the science-based reality. If the public does not 
perceive a risk, they won’t respond adequately 
to prevent it.
• Gauging public perceptions can be done 
through polling, hotlines or social media.
• Find out the beliefs of the community and in-
clude them in your messages and actions.
PLANNING 
Risk communication works best when it is part of 
a larger plan or strategy outlined long before it is 
needed. That may not be the case with COVID-19, 
so what follows are checklists and templates.
3II. Overall 
Communication 
Goals for a COVID-19 
Outbreak 
• Immediately communicate accurate, timely in-
formation and address public health concerns 
about the first laboratory-confirmed case of 
COVID-19.
• Instill and maintain public confidence in the 
government’s public health system to effective-
ly respond to and manage the situation.
• Keep the public fully informed — explain what 
we know and what we don’t know — so that the 
public understands their personal level of risk 
of COVID-19 infection and behaves accordingly. 
• Maintain credibility and public trust by provid-
ing accurate, science-based information but 
also recognizing the uncertainty with honesty, 
knowledge and commitment.
• Avoid speculation and conjecture. Dispel ru-
mors, misinformation, and misperceptions as 
quickly as possible. 
• Protect the privacy of the patients and contacts 
to the extent possible. 
• Respond rapidly to the specific concerns and in-
formation needs of the public, healthcare work-
ers, and the public health community. 
• Employ a unified and consistent government ap-
proach to strategic and operational communication. 
• Stay connected with the local hospital and local 
health departments, not just for the initial an-
nouncement but also in the days following. Keep 
messaging alignment between government , hospi-
tal, and local health authorities. 
• Proactively share public information about the 
first case with local, national and international 
counterparts to maximize public awareness and 
interagency consistency of COVID-19 messaging.
• Tell people what they can do to reduce their 
exposure to the virus and protect the health of 
their loved ones, according to their risk, level of 
concern, and the available recommendations 
and options. This provides a sense of motiva-
tion and greater control.
4III. Key  
Assumptions and 
Considerations
• As more cases of COVID-19 develop internation-
ally, it is possible that one or more cases will be 
diagnosed in countries of Latin America and 
the Caribbean. 
• The news media or social media may be the first 
to unofficially announce or speculate that a sus-
pected or confirmed case of COVID-19 has been 
identified in your country. There may be several 
suspected cases that turn out not to be COVID-19.
• There will be a delay between the reports of the 
first suspected and confirmed case(s); the lon-
ger this period of time, the greater the degree of 
media and public speculation.
• Travelers may not have had symptoms while 
traveling but may have exhibited symptoms 
after being in another country for a while and 
traversing through several places. Assessing 
the traveler’s movements and potential con-
tacts with others will be necessary to anticipate 
public fear in the case that the person interacted 
with others (e.g., in businesses, schools).
• The time from positive confirmation of the first 
case to public announcement should be very 
short.
• The patient(s) in question will have been isolat-
ed, and active contact tracing will have begun/
will begin immediately.
• There will be high demand for information 
from the public and from domestic and interna-
tional media.
• Social media will exponentially compound the 
pressure and demand for information as well 
as greatly expand the potential for misinforma-
tion and rumors to spread rapidly.
• There will be incomplete information, misin-
formation, rumors, and misconceptions among 
the public. People may take actions based on 
this information.
• There could be delays in obtaining and releas-
ing verified information to the public; the lon-
ger the delay, the greater the degree of news 
media and public speculation.
• There will be immediate and ongoing demands 
for information and products from health au-
thorities, partners, news media, policy makers, 
the general public, and other audiences. This 
demand will place significant pressure on the 
government to provide facts quickly.
• Health guidance and recommendations may 
change as we learn more about COVID-19. But 
officials need to immediately inform the public 
and other stakeholders of new recommenda-
tions as they are developed.
5COVID-19 is a new respiratory illness that was first discovered in Wuhan, China. It is  
transmitted from person to person.
Who is most at risk of becoming seriously ill?
• People over age 60 
• People with pre-existing conditions such as diabetes and heart disease
How is it transmitted?
• Through close contact with an infected person
• By
 
an infected person coughing or sneezing
• By touching contaminated objects or surfaces and then touching your mouth, nose or eyes
Currently there is no vaccine or specific treatment. We can only treat the symptoms.
Serious cases may require oxygen and ventilatory
 
support.
*Symptoms may appear 1 to 12 days following exposure to the virus
BE AWARE.
PREPARE.
common
symptoms
severe
cases
ACT.
severe respiratory diseasePneumoniaHigh fever
Symptoms*
Wash your hands regularly with soap and water or 
use an alcohol-based gel.
Avoid sharing cups, plates or other personal items 
and disinfect all surfaces that are touched 
frequently.
Make sure you get your information from a 
reliable source.
If you have traveled to areas where COVID-19 is
 
circulating or have been in contact with someone 
who has it and you experience fever, cough or 
difficulty breathing, seek medical attention 
immediately. Do not self-medicate.
Cover your mouth with the inside of your elbow when you 
cough or sneeze or use a tissue and dispose of used tissue 
immediately and wash your hands.
 
Note: Information may change when more is known about the disease.
 
February 2020.
Sore ThroatRunny nose cough 
Avoid close contact with people who 
have flu-like symptoms.
Avoid touching your eyes, nose or mouth with 
unwashed hands.
Coronavirus Disease 2019
OVID-19
6IV. Messages
1. Who is in charge and what are they doing to 
investigate and control the situation?
2. What are health authorities doing to address 
this situation? Health departments? Hospital? 
Airline? Border protection?
3. Where and how did the patient get COVID-19?
4. Did the infected patient spread COVID-19 to 
other people? How?
5. What are the risks to people who had close 
contact with the patient?
6. What are the risks to other passengers on the 
airplane (if patient arrived by plane)?
7. What are the risks to healthcare workers and 
other patients in the hospital? What is the risk 
to the community?
8. Who will notify patients and families of 
possible exposures and risks? How?
9. What is the hospital doing to prevent spread 
within the hospital and to other patients?
10. What if COVID-19 spreads and causes an 
outbreak in (name of your country)?
11. What should I do if I had close contact with 
the patient?
12. Did (or is) the hospital follow(ing) infection 
control practices?
13. Did (or is) the airline crew and border control 
officers follow(ing) the appropriate steps?
14. From what country did the patient come? 
What steps did the country take, if any, to 
prevent the first case from traveling?
To avoid confusion about the initial appearance of cases, prevent disease spread and create trust in author-
ities’ response to the virus, messages should be timely, accurate, actionable, and relevant to the audience. 
Messages should be updated as soon as new information is verified.
Specific questions about the first diagnosed case of COVID-19 that might come up are below. Health authori-
ties should consider beforehand how they will answer these questions if/when a first case is diagnosed.
715. Was the infected patient isolated?
16. Are the patient’s contacts being isolated? 
Why? 
17. Are there likely to be more cases? What can be 
done to prevent them?
18. Is the virus circulating in (name of your 
country)?
19. Are we prepared for an outbreak?
20. Are hospitals prepared to respond?
21. Do hospital staff have enough personal 
protective equipment?
22. How can I protect myself and my family from 
COVID-19?
23. Was the airplane quarantined?
24. Was there adequate warning that this could 
happen?
25. What is being done at the airports and other 
points of entry to screen arriving travelers?
26. Will borders be closed?
27. What are the symptoms of COVID-19? When 
should I see a doctor?
28. Are there antiviral treatments or other 
treatments? Is there a vaccine? Will it be 
available for everyone?
29. Should we ban incoming flights or travelers 
from affected countries?
30. Should we be worried?
8V. Draft Key  
Points for First  
Case of Imported 
COVID-19
Examples of main key points: 
• The first diagnosed case of COVID-19 has been 
reported in your country.
• The Ministry of Health knows that people are 
concerned. We understand these concerns and 
are taking this very seriously. We will share the 
information we have now and additional infor-
mation as soon as we have it.
• Right now, we know that one person was con-
firmed to have COVID-19 virus infection. 
 » The patient developed COVID-19 symptoms 
and was hospitalized in [insert place] on [in-
sert date].
 » The patient had recently traveled from [insert 
country] and became ill approximately [insert 
date relative to arrival in your country].
• This situation is still evolving. [Names of minis-
tries] are investigating—
 » How the patient became infected with 
COVID-19 virus
 » How many people had close contact with the 
patient once symptoms developed and their 
current health status
• The Ministry of Health is working closely with 
other ministries to rapidly investigate this situ-
ation and to help prevent the spread of COVID-
19. We are currently: 
 » Making sure the patient is receiving treat-
ment and is isolated
 » Interviewing the patient and close contacts, 
such as family members, to obtain detailed 
information on their travel history and ex-
posures
 » Ensuring the hospital uses appropriate infec-
tion control measures
 » Identifying people who had close contact 
with the patient and
• interviewing them
• monitoring them to see if they become ill
• collecting and testing specimens from 
them, if needed
• requesting that they monitor their health 
and seek care if they develop symptoms 
 » Monitoring the health status of healthcare 
workers who cared for the patient.
• Currently, there is no vaccine to protect against 
COVID-19 infection. Standard treatment for 
COVID-19 is limited to treating the symptoms as 
they appear and supportive care.
9• The government has been preparing for an 
event like this as part of the International 
Health Regulations. We have been:
 » Enhancing surveillance and laboratory test-
ing to detect cases
 » Providing recommendations for healthcare 
infection control and other measures to pre-
vent disease spread
 » Working to inform healthcare providers 
about proper response protocols
 » Disseminating up-to-date information to the 
general public, international travelers, and 
public health partners
• Travelers who have visited countries where 
the virus is currently circulating or who were 
in contact with anyone with the virus should 
monitor their health for symptoms such as 
fever, cough or pneumonia for 14 days after re-
turning home. If symptoms appear, they should 
take recommended measures to prevent spread 
of the virus and seek medical care, informing 
their healthcare provider of their travel history. 
• Healthcare workers should consider COVID-19 
in patients who develop fever, cough or pneu-
monia up to 14 days after traveling to any place 
where the virus is circulating or if the patient 
may have had contact with an infected person. 
They should immediately implement appropri-
ate infection control precautions and contact 
the Health Ministry if they have any questions.
• The Ministry of Health will post new informa-
tion about COVID-19 on the website: www.
• When health risks are uncertain, people need 
information about what is known and un-
known, and interim guidance to make deci-
sions to help protect their health and the health 
of others. 
• Even one case of COVID-19 will generate imme-
diate, intense, and sustained demand for infor-
mation from the public, healthcare providers, 
policymakers, and the news media. It can also 
create demand for healthcare services.
• Timely and transparent dissemination of accu-
rate, science-based information can build pub-
lic trust and confidence.
10
Guiding Risk 
Communication 
Principles
This guidance employs basic risk communica-
tion principles in order to establish and main-
tain public trust and manage the expectations of 
citizens during an extremely adverse situation 
over an extended duration. 
These principles are based on and complement 
the WHO Outbreak Communication Guidelines 
(http://www.who.int/csr/resources/publications/
WHO_CDS_2005_28/en/).
When health risks are uncertain, as likely will be 
the case following the first case(s) of COVID-19 di-
agnosed in your country, people need information 
about what is known and unknown about the virus, 
their actual degree of risk, and interim guidance to 
formulate decisions to help protect their health and 
the health of others. To the extent possible, provid-
ing this information in advance of the first diag-
nosed case will help mitigate initial concerns.
The first diagnosis of COVID-19 in your country 
will likely generate immediate, intense, and sus-
tained demand for information from the public, 
healthcare providers, policymakers, and news 
media. Healthcare workers and public health staff 
may need training in media relations and public 
health and risk communication.
Timely and transparent dissemination of accurate 
and accessible science-based information about 
COVID-19 can build public trust and confidence, 
particularly when such communication efforts are 
guided by established principles of risk communi-
cation.
Coordination of message development and release 
of information among all responding organiza-
tions, international partners and health officials 
is critical to help avoid confusion that can under-
mine public trust, raise fear and anxiety, and im-
pede response measures.
Information to public audiences should be acces-
sible, technically correct, honest, transparent, and 
sufficiently complete to encourage support of poli-
cies and official actions without seeming patroniz-
ing to the public.
Information presented should minimize specula-
tion and avoid overinterpretation of data as well 
as overly confident assessments of public health 
investigations and control measures.
It will be important to make clear that our guid-
ance and recommendations may change as we 
learn more about this new disease.


